Skip to Main Content

Paper Details

Mutations driving CLL and their evolution in progression and relapse.
Nature
743
2015
CLL, DNA samples, IKZF3, MAPK, MYC, RNA, RPS15, cancer, chronic lymphocytic leukaemia, mutated genes, novel genes, patients
Author NameAffiliation
Dan A LandauBroad Institute of Harvard and MIT
Dan A LandauHarvard Medical School
Dan A LandauBrigham and Women's Hospital
Dan A LandauDana-Farber Cancer Institute
Amaro Taylor-WeinerBroad Institute of Harvard and MIT
Chip StewartBroad Institute of Harvard and MIT
Chip StewartBroad Institute of Harvard and MIT
Michael S LawrenceBroad Institute of Harvard and MIT
Scott L CarterBroad Institute of Harvard and MIT
Scott L CarterJoint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Kristian CibulskisBroad Institute of Harvard and MIT
Carrie SougnezBroad Institute of Harvard and MIT
Carrie SougnezBroad Institute of Harvard and MIT
Mara RosenbergBroad Institute of Harvard and MIT
Mara RosenbergBroad Institute of Harvard and MIT
Julian M HessBroad Institute of Harvard and MIT
Julian M HessBroad Institute of Harvard and MIT
Stacey GabrielBroad Institute of Harvard and MIT
Stacey GabrielBroad Institute of Harvard and MIT
Eric S LanderBroad Institute of Harvard and MIT
Eric S LanderBroad Institute of Harvard and MIT
Donna NeubergDana-Farber Cancer Institute
Gad GetzBroad Institute of Harvard and MIT
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Gad GetzBroad Institute of Harvard and MIT
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Catherine J WuBroad Institute of Harvard and MIT
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBrigham and Women's Hospital
Catherine J WuHarvard Medical School
  • 1 - 30

Datasets